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Healthy Nordic diet modulates the expression of genes related to mitochondrial function and 
immune response in peripheral blood mononuclear cells from subjects with the metabolic syndrome 
– a SYSDIET sub-study 
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Abbreviations: ND: healthy Nordic diet, CD: control diet, PBMCs: peripheral blood 
mononuclear cells, T2DM: type 2 diabetes mellitus, CVD: cardiovascular diseases, IR: 
insulin resistance, MetS: metabolic syndrome, PUFA: polyunsaturated-fatty acid, SFA: 
saturated fatty acid, ROS: reactive oxygen species, FDR: false discovery rate, ETC: electron 
transport chain, OXPHOS: oxidative phosphorylation, SCFAs: short-chain fatty acids. 
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Abstract 
Scope: To explore the effect of a healthy Nordic diet on the global transcriptome profile in 
peripheral blood mononuclear cells (PBMCs) of subjects with the metabolic syndrome. 
Methods and Results: Subjects with the metabolic syndrome underwent an 18/24 week 
randomized intervention study comparing an isocaloric healthy Nordic diet with an average 
habitual Nordic diet served as control (SYSDIET study). Altogether, 68 participants were 
included. PBMCs were obtained before and after intervention and total RNA was subjected to 
global transcriptome analysis. 1302 probe sets were differentially expressed between the diet 
groups (p-value < 0.05). Twenty-five of these were significantly regulated (FDR q-value < 
0.25) and were mainly involved in mitochondrial function, cell growth and cell adhesion. The 
list of 1302 regulated probe sets was subjected to functional analyses. Pathways and 
processes involved in the mitochondrial electron transport chain, immune response and cell 
cycle were down-regulated in the healthy Nordic diet group. In addition, gene transcripts with 
common motifs for 42 transcription factors including NFR1, NFR2 and NF-B, were down-
regulated in the healthy Nordic diet group. 
Conclusion: These results suggests that benefits of a healthy diet may be mediated by 
improved mitochondrial function and reduced inflammation. 
 
www.mnf-journal.com Page 5 Molecular Nutrition & Food Research 
5 
This article is protected by copyright. All rights reserved. 
 
 
Graphical abstract-Figure legend 
 
Subjects (n=68) with the metabolic syndrome underwent an 18/24 week randomized 
intervention study comparing an isocaloric ND with an average habitual Nordic diet served as 
control (CD). Total RNA isolated from PBMCs was subjected to microarray analysis. 1302 
probe sets were differentially expressed between the diet groups (p-value < 0.05). 25 of these 
were significantly regulated (FDR q-value < 0.25) and were mainly involved in 
mitochondrial function, cell growth and cell adhesion/T-cell activation. The list of 1302 
regulated probe sets was subjected to functional analyses. Pathways and processes involved 
in the mitochondrial function, immune response and cell cycle were down-regulated in the 
ND compared to the CD group. In addition, gene transcripts with common motifs for 42 
transcription factors including NFR1, NFR2 and NF-B, were down-regulated. A healthy 
Nordic dietary pattern modulates the expression of genes involved in mitochondrial function 
and immune response in PBMCs of subjects with the metabolic syndrome. ND: healthy 
Nordic diet, CD: control diet, PBMCs: peripheral blood mononuclear cells, MetS: metabolic 
syndrome, ETC: electron transport chain, NRF1: nuclear respiratory factor 1, NRF2: nuclear 
respiratory factor 2. BP: biological process, TF: transcription factor, FDR: false discovery 
rate. 
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Introduction  
Metabolic syndrome (MetS) represents a cluster of related risk factors, including 
glucose intolerance, hypertension, dyslipidemia and central obesity, which increase the risk 
of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) 
[1]
. Obesity, insulin 
resistance (IR) and T2DM are associated with chronic low-grade inflammation, characterized 
by abnormal cytokine production, and increased levels of acute-phase reactants 
[2-4]
. 
Furthermore, increased reactive oxygen species (ROS) production caused by mitochondrial 
dysfunction has recently shown to be involved in the pathogenesis of IR, T2DM and MetS 
[5-
7]
. Mitochondria have also been recognized as key players in the inflammatory responses by 
linking ROS to production of proinflammatory signaling and inflammasome activation 
[8]
. 
Excessive energy intake, unhealthy diet and sedentary lifestyle, all modifiable factors, 
increase the risk of developing both the MetS and T2DM 
[9]
. Therefore, lifestyle changes are 
important when attempting to reduce the risk of these metabolic diseases 
[10, 11]
. 
Epidemiological and dietary intervention studies have demonstrated that a traditional 
Mediterranean dietary pattern rich in whole-grains, fruits, vegetables, nuts, and olive oil, is 
associated with lower risk of MetS 
[9, 12, 13]
. A healthy Nordic diet resembling the 
Mediterranean diet has also shown to improve cardiovascular risk factors in obese and 
hypercholesterolaemic subjects 
[14, 15]
. We have previously shown that a healthy Nordic diet 
(ND) improved risk factors, such as cholesterol, blood pressure and inflammation  related to 
the development of T2DM and atherosclerosis in subjects with the MetS when compared to 
the current average habitual Nordic diet defined as the control diet (CD) (The SYSDIET 
study) 
[16, 17]
. The ND was based on Nordic and local food items, such as whole-grain 
products, abundant use of berries, fruit and vegetables, rapeseed oil, three fish meals per 
week and low-fat dairy products. In a sub-study of SYSDIET, the transcriptome profile of 
subcutaneous adipose tissue was altered and genes related to inflammation were significantly 
www.mnf-journal.com Page 8 Molecular Nutrition & Food Research 
8 
This article is protected by copyright. All rights reserved. 
different expressed after intake of ND
 [18]
. There is, however, a lack of clarity in relation to 
the molecular mechanisms involved in the beneficial effect of a healthy diet on 
cardiovascular risk factors. 
The peripheral blood mononuclear cells (PBMCs) are immune cells consisting mostly 
of monocytes and lymphocytes. These cells are exposed to many of the same environmental 
factors as metabolically active tissues and the arterial wall, and can give us additional 
information on how the diet influences metabolic regulation. Given the notion that PBMCs 
are central in the process of inflammation, these cells may constitute a link between systemic 
inflammation, diet, metabolic changes in peripheral tissues and the development of 
atherosclerosis and IR 
[19]
. Nutrition-related metabolic changes such as fasting have been 
shown to alter the PBMC gene expression profile 
[20]
. Furthermore, diets and dietary factors 
have been reported to modulate expression of genes involved in inflammation, oxidative 
stress and lipid metabolism in PBMCs 
[21-26]
. A traditional Mediterranean diet was shown to 
modulate the transcriptome profile related to a reduced CVD risk in PBMCs 
[27]
.  
In the present sub-study of the SYSDIET, our specific aim was to further explore the  
effect of a ND by investigating the global transcriptome profile of PBMCs in subjects with 
features of the MetS. We demonstrate that a ND significantly modulates the transcriptome 
profile compared to the current average habitual diet in the Nordic countries. 
Materials and Methods 
Design of the SYSDIET study 
The SYSDIET study was a randomized controlled multi-center study performed in six 
centers (Kuopio and Oulu (Finland), Lund and Uppsala (Sweden), Aarhus (Denmark) and 
Reykjavik (Iceland)) as previously described 
[16]
. The primary outcome was insulin sensitivity 
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and glucose tolerance, and among the main secondary outcomes were other traits related to 
MetS, i.e. blood pressure and serum lipid profile, inflammatory markers and transcriptome 
data. Details of the study design and the main measurements performed are described in the 
original publication 
[16]
. Briefly, after a one-month run-in period during which all participants 
followed their habitual diet, participants fulfilling the inclusion criteria were randomized into 
the CD group or the ND group for the next 18 to 24 weeks. Randomization was performed at 
each center by matching according to gender and medians of age, BMI and fasting plasma 
glucose at screening, resulting in equal amounts of certain strata classes amongst the groups. 
The major visits were in the beginning (0 week) and at 12 and either 18 or 24 weeks (end of 
the study). The study participants were advised to keep their body weight and physical 
activity level constant and not to change their smoking or drinking habits or drug treatment 
during the study. PBMCs were not collected from the study center of Aarhus, and few 
subjects donated PBMCs from the study centers at Uppsala and Reykjavik. Therefore only 
subjects from the study centers in Kuopio and Oulu, Finland and from Lund, Sweden, were 
included in this current SYSDIET sub-study. All study participants provided written 
informed consent and local Ethics committees (Research Ethics Committee of the Hospital 
District of Northern Savo and Northern Ostrobothnia Hospital District, Oulu, Finland and 
Regional Ethical Review Board, Lund) approved the study protocol in accordance with the 
Helsinki Declaration. The study was registered at clinicaltrials.gov as NCT00992641. 
 Screening of study participants and inclusion/exclusion criteria 
A screening examination was carried out 4 weeks before the study. This visit included 
medical history, and clinical examination 
[16]
. The inclusion criteria were age 30 to 65 years, 
BMI 27- 39 kg/m
2
, and two other of the International Diabetes Federation (IDF) criteria for 
MetS 
[28]
. Anti-hypertensive and lipid lowering medication were allowed but without changes 
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during the trial.
 
The main exclusion criteria included any chronic disease and condition, 
which could hamper the adherence to the dietary intervention protocol, chronic liver, thyroid 
and kidney diseases, alcohol abuse (> 40 g/d), diabetes, fasting triglycerides > 3.0 mmol/l, 
total cholesterol > 6.5 mmol/l and blood pressure > 160/100 mmHg.  
For this sub-study of SYSDIET, we included participants who had donated PBMCs in 
Kuopio, Lund and Oulu (n=68, 42 in the ND group and 26 in the CD group) with a maximum 
weight change during the study of +/- 4 kg, no use of statins, high-sensitivity (hs) C-reactive 
protein (CRP) < 10 mg/L at baseline and at the end of the intervention (Figure 1). The study 
was originally designed to last for 24 weeks. Due to problems with recruitment, the original 
protocol was changed and a shorter intervention period at some of the study centers was 
included after the trial was started. Therefore, two of the centers included had 24 weeks of 
study length (Kuopio and Lund) and one center 18 weeks of study length (Oulu) 
[16]
. For 
verification of selected target genes with RT-qPCR, the same criteria for inclusion was used 
(Figure 1). The three remaining study centers (Aarhus, Uppsala and Iceland) were not 
included in the transcriptome analyses or the RT-qPCR analyses as they did not isolate 
PBMCs (Aarhus n=31) or included a limited number of participants and PBMC samples in 
the study (Uppsala n=9 and Reykjavik n=15). 
Diet 
The nutrient composition of the isocaloric diets is extensively described elsewhere 
[16]
. 
Briefly, Nordic nutrition recommendations formed the basis for the ND 
[29]
. The main 
emphasis was on food items such as whole-grain products, abundant use of berries, fruits and 
vegetables, rapeseed oil, three fish meals per week, low fat dairy products and avoidance of 
sugar-sweetened products. The current average diet in the Nordic countries formed the basis 
for the CD and the individuals in the CD group received low fiber cereal products, e.g. breads 
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with fiber content less than 6 g/100 g, and dairy fat based spread e.g. a butter-vegetable oil 
mixture. Key food products were provided to the study participants in both groups. 
A clinical nutritionist or a dietician instructed about the diets at the first visit (week 0). 
The study participants kept 4-day dietary records during the run-in period (baseline intake) 
and three times (weeks 2, 11 and 17 or 23) during the intervention period to assess the total 
diet.  
Biochemical and anthropometric measurements 
Screening laboratory measurements, fasting glucose, total lipid and lipoprotein 
concentrations and anthropometric measurements were performed locally according to the 
standard operational procedures agreed by all centers.  
Sampling of PBMCs, RNA extraction, microarray hybridization  
PBMCs were isolated within 30 to 45 min from blood samples collected after 
overnight fasting (12h) at each study center using cell preparation tubes (CPT) according to a 
standard operational procedure (SOP) based on the manufacturer’s instructions (Becton, 
Dickinson and Company, Franklin Lakes, NJ, USA). This is a standardized method to collect 
mononuclear cells with high purity (above 90%), and according to the manufacturer, 
approximately 80% of the cells are lymphocytes and 12% are monocytes. The PBMC pellet 
was immediately stored at -80
o
C. At the end of the study, all samples were shipped on dry-ice 
to Karolinska Institute, Sweden. The number of monocytes and lymphocytes were counted 
and did not change before and after intervention in ND compared to the CD group (data not 
shown).Total RNA from the PBMCs from all centers was isolated and prepared at the same 
time in the same laboratory (Karolinska Institute, Stockholm). Total RNA was extracted 
using the RNeasy Mini Kit according to the manufacturer’s instructions (Qiagen, Valencia, 
CA, USA). Contamination of DNA was removed during RNA isolation with DNase. RNA 
www.mnf-journal.com Page 12 Molecular Nutrition & Food Research 
12 
This article is protected by copyright. All rights reserved. 
integrity was checked using Bioanalyzer device (Agilent 2100 Bioanalyzer, Agilent 
Technologies, Santa Clara, CA, USA). RIN value below 8 was consider poor RNA quality.  
Two samples were excluded due to low RNA yield. Therefore, RNA samples from 40 
participants from the ND group and 26 from the CD group were labeled (cRNA) and served 
as template for hybridization to the Human Gene ST 1.1 Arrays (Affymetrix, Inc., Santa 
Clara, CA, USA) according to the manufacturer’s standard protocols. The Affymetrix CEL 
files (containing probe intensities) were imported into Partek Genomics Suite software 
(Partek, Inc. MO, USA) for further processing. Robust microarray analysis (RMA) yielding 
normalized log2 transformed signal intensities was applied for normalization. Gene 
transcripts with maximal signal values of less than 5 (Log2 values) across all arrays were 
removed to filter for low and non-expressed genes, reducing the number of probe sets from 
33,297 to 16,831.  
RT-qPCR 
RNA was reverse transcribed by a high-capacity cDNA reverse transcription kit 
(Applied Biosystems). The concentrations of RNA ranged between 71.9 and 247.1 ng/ul and 
500 ng of RNA was used in the cDNA reactions to a final yield of 25 ng/ul cDNA.RT-qPCR 
was performed on an ABI PRISM 7900HT (Applied Biosystems) with inventoried TaqMan 
gene expression assays for carbohydrate sulfotransferase 10 (CHST10, Hs01556595_m1), 
dihydrofolate reductase (DHFR, Hs00758822_s1), DAN family BMP antagonist (NBL1, 
Hs01556595_m2) and ubiquinol-cytochrome c reductase complex assembly factor 3 
(UQCC3, Hs03054640_g1) (Thermo Fisher Scientific). TATA-binding protein (TBP, 
Hs00427620_m1) and glucuronidase beta (GUSB, Hs00939627_m1) was chosen as reference 
genes due to previous experience with these genes in PBMCs 
[30]
. The assays used for the 
selected genes were chosen due to best coverage according to thermos Fischer. 
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The relative mRNA level for each transcript was calculated by the ∆∆cycle threshold 
(Ct) method 
[31]
. Ct values for each target gene were normalized to the average Ct value of the 
reference genes (Ctreference – Cttarget = ∆Ct) and the relative change from baseline to the end of 
study visits was calculated and expressed as log ratio (∆Ctend of study - ∆Ctbaseline = ∆∆Ct). 
Statistical and functional analyses 
For the microarray analyses, diet-induced changes in gene expression were obtained 
by calculating the signal log2 ratio between the 18/24 weeks and baseline intensities for each 
probe set. Differentially expressed probe sets between ND and CD were determined in R 
(version 3.5.1) with a linear regression model adjusted for age, gender and study center and 
with log ratio as the dependent variable. To account for multiple testing, we applied false 
discovery rate (FDR) analyses and a q-value < 0.25 was considered significant. Furthermore, 
a list of 1302 probe sets differently regulated by the two diets with a p-value  < 0.05 were 
subjected to functional analyses with the software tool MetaCore (GeneGo, division of 
Thomson Reuters, St. Joseph, MI, USA) and the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) v6.8 (https://david.ncifcrf.gov/).  
For RT-qPCR analyses, differences in gene expression between diets were tested with 
a linear regression model adjusted for age, gender and study center with log ratio as the 
dependent variable. Statistical analyses were performed in R version 3.5.1. Gene transcripts 
with a p-value < 0.05 were defined as significant changed between diets. 
For the biochemical,anthropometric measurements, and dietary changes linear mixed-
effects models (nlme package version 3.1-108) were used to analyze the differences between 
the two groups as previously described 
[16]
. 
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Results 
Subject characteristics, dietary data and clinical and biochemical 
variables 
A total of 66 subjects (n=40 ND group, n=26 CD group) were included in the analyses 
of the present study (Figure 1) and their baseline characteristics are shown in Table 1. The 
baseline characteristics did not differ between the two groups. During the intervention, the 
nutrient intakes in this subpopulation of participants were in agreement with the results 
obtained for the whole study population 
[16]
. The polyunsaturated fatty acid (PUFA), -
carotene and fiber intake were higher, and the saturated fatty acid (SFA), intake were lower 
in the ND group compared to the CD group. However, in contrast to the whole study 
population, protein, salt and alcohol intakes did not differ significantly between the groups in 
the present subpopulation during the intervention (Table 2). Changes in clinical and 
biochemical variables were in agreement with the whole study population 
[16]
. In particular, 
the IL1Ra plasma concentration was markedly decreased in the ND group compared to the 
CD group (Table 3). In the ND group, we also observed a decrease in LDL cholesterol 
concentration compared to the CD group in line with the main study (Table 3).  
Gene expression profiling in PBMCs 
Microarray hybridization was performed on RNA from PBMCs collected at baseline 
and at the end of the intervention (18 or 24 weeks). From the 33,297 probe sets presented on 
the microarray, 16,831 were defined as expressed and included in the statistical analyses. 
Diet-induced changes in gene expression were obtained by calculating the log2 ratio between 
the 18/24 weeks and baseline intensities for each probe set. The log2 ratio for ND was then 
compared to the log2 for the CD in the linear regression analyses. Overall, 1302 probe sets 
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were identified to be differentially expressed between the two intervention groups (p-value < 
0.05) (Table S1) and used for further functional analyses to identify groups of regulated gene 
transcripts (see below). In order to identify significantly expressed gene transcripts between 
the two diet groups we adjusted the p-value for multiple testing and 25 probe sets were 
significantly altered with a FDR q-value < 0.25 (Table 4). The ND diet led to a down-
regulation of 22 gene transcripts and up-regulation of three gene transcripts compared to the 
CD diet (Table 4). The down-regulated gene transcripts were related to cellular processes 
such as cell division, -proliferation and -growth (DHFR, KNSTRN, OGFR, MRGBP, PPAI), 
DNA damage and -repair and apoptosis (UBE2A, ZBTB33, FAAP20, ATRAID), cell adhesion 
(CHRIST10, CLDN15), ribosomal biogenesis (RPL14), protein modification such as 
palmitoylation (ZDHHC5) and glycosylation (ALG14, POMGNT2). In addition, several of 
the down-regulated gene transcripts were involved in mitochondrial functions such as the 
respiratory chain (UQCC3), protein folding (CHCHD5), mitochondrial transport (SLC25A19) 
or located within the mitochondria (TRUB2, ALDH1B1).  
Four genes (DHFR, CHST10, UQCC3 and NBL1) among the most regulated (FDR q-
value < 0.25) and involved in different cellular processes (Table 4) were selected for 
confirmation by RT-qPCR analyses. The mRNA level of CHST10 (p = 0.02) and UQCC3 (p-
value = 0.01) were significantly decreased in the ND group compared to the CD group. In 
addition, the mean log ratio level measured with RT-qPCR was similar for these gene 
transcripts compared to the level obtained with the microarray analyses (Figure 2). The 
mRNA level of DHFR was also decreased in the ND group compared to the CD group. 
Although the difference was not significant (p-value = 0.08), the mean effect was in the same 
direction as in the microarray analyses (Figure 2). In contrast to the microarray results, we 
were not able to detect any expression level of NBL1 with the RT-qPCR method. 
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Pathways and Processes modulated by the intervention diets 
To further identify differences across the two groups, we analyzed functional 
relationships among the 1302 differentially expressed probe sets (p-value < 0.05) using the 
software tools Metacore and DAVID. The gene list was divided into down- and up- regulated 
gene transcripts in the ND group when compared to the CD group and subjected to the 
software tools, separately. Altogether, five pathway maps were significantly modulated (FDR 
q-value < 0.05) between the groups among the 927 down-regulated gene transcripts using 
Metacore. The down-regulated pathways were involved in immune response, ubiquinone 
metabolism, neurophysiological process, regulation of degradation of deltaF508-CFTR and 
cytoskeleton remodeling (Table 5). In addition, we identified ten significantly enriched 
biological processes (FDR q-value < 0.05) in the list of down-regulated gene transcripts, by 
the use of the annotation tool DAVID (Table 6). These were related to mitochondrial 
function, cell cycle, transcription and translation processes.  
To further explore the the changes in gene expression, transcription factor analyses 
were performed using Metacore with the list of down-regulated probe sets. Genes with 
binding sites for 42 transcription factors were overrepresented among the 927 probe sets 
(Table 7). Of particular interest is the increased occurrence of genes with binding sites for 
both the NF-B subunits RelB and RelA (p65), SREBP1 and 2, IRF2, LXR and , YY1, 
NRF2, NRF1 and p53. The transcription factor p53 was also present in the list of the down-
regulated gene transcripts (Table 7 and Table S1), in addition to Miz-1 and NRF1 (Table 7). 
One pathway map involved in cytoskeleton remodeling was significantly modulated 
(FDR q-value <0.05) among the 375 up-regulated gene transcripts in the ND compared to CD 
group (Table 8). In addition, binding sites for two transcription factors were overrepresented 
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among the 375 up-regulated probe sets (CBFA2T3 and CREB1) as shown in Table 9. No 
significant enriched biological processes were identified among the up-regulated probe sets. 
Discussion 
We have investigated the impact of a ND compared to a CD on the global 
transcriptome profile of PBMCs in subjects with MetS participating in a multi-center dietary 
intervention study for 18/24 weeks. The significant changes in gene transcripts involved in 
mitochondrial function, cell growth and cell adhesion were of particular interest. 
Furthermore, functional annotation analyses showed that pathways and processes related to 
immune response and mitochondrial electron transport chain (ETC) were enriched among the 
down-regulated gene transcripts after intake of ND compared to CD.  
In the current study, UQCC3 was significantly down-regulated after the intake of ND 
compared to CD (Table 3 and Figure 2). The decreased mRNA expression in the ND group 
was also confirmed with the use of RT-qPCR. The protein encoded by UQCC3 is associated 
with the bc1 complex of the ETC 
[32]
. Furthermore, several processes and one pathway related 
to ETC and respiratory chain in addition to genes with regulatory motifs for the transcription 
factors NRF1 and 2, were down-regulated in the ND group. NRF1 and 2 are nuclear 
transcription factors that, together with the transcriptional co-activator PGC1-a, stimulate the 
expression of a broad set of genes involved in mitochondrial biogenesis and functions 
[33]
. In 
accordance to our results, decreased expression of genes linked to mitochondrial function has 
previously been observed in PBMCs in human dietary intervention studies. Intake of a diet 
rich in monounsaturated fat or a Mediterranean diet was found to decrease expression of 
genes linked to oxidative phosphorylation (OXPHOS) in PBMCs compared with a diet rich 
in SFA 
[22]
. In addition, caloric restriction, which is considered beneficial for longevity and 
CVD, decreased expression of genes involved in OXPHOS in a human study 
[34]
. The ETC is 
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the major site of production of ROS in the cells. Mitochondrial alterations may lead to 
increased production of mitochondrial-derived ROS, promote inflammation and thereby 
contribute to the development of metabolic disorders such as IR, T2DM and obesity 
[35-37]
. A 
healthy dietary pattern, such as a healthy Nordic diet, may thus improve health by altering 
expression of genes related to mitochondrial function and thereby reduce ROS production. 
The mechanism behind this change is currently unknown. In animal studies, dietary fat has 
shown to influence the composition of the mitochondrial membrane and thereby the 
mitochondrial function 
[38-40]
. Furthermore, intake of n-3 PUFA has been shown to reduce 
ATP production and respiratory chain activity in mice 
[41, 42]
. 
In the present study, the ND down-regulated a pathway related to immune response as 
compared to the CD.  In addition, gene transcripts with binding sites for both the NF-B 
subunits RelB and RelA were overrepresented within the regulatory region of genes 
significantly down-regulated in the ND compared to the CD group. ND significantly down-
regulated the gene expression of toll-like receptor 4, which is central in NF-KB signaling, in 
PBMC during a glucose challenge test in the same study [43]. In addition, NF-B target 
genes and several immune related gene transcripts were down-regulated in the adipose tissue 
after intake of ND compared to CD 
[18]
. In the current study, we also identified gene 
transcripts related to immune function that were down-regulated, such as CHST10. 
Furthermore, the decreased mRNA expression of CHST10 was confirmed with RT-qPCR 
analyses. CHST10 encodes a protein with sulfotransferase activity, involved in T-cell 
adhesion and activation 
[44]
. Activated T cells in adipose tissue are important mediators of 
local inflammation and metabolic dysfunction 
[45]
. Regulation of gene transcripts in PBMCs 
related to immune response and inflammation have previously been reported in dietary 
intervention studies. In a randomized controlled trial, a traditional Mediterranean diet 
supplemented with olive oil decreased the expression of inflammatory genes in PBMCs in 
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subjects with CVD and overall modulated biological pathways related to CVD 
[27]
. 
Furthermore, intake of olive oil in a postprandial study down-regulated IFNG gene 
expression in PBMCs 
[46]
 and sustained consumption of olive oil with high polyphenol 
content showed similar effect 
[47]
. The healthy Nordic diet is in many respects similar to the 
Mediterranean diet, where the intake of SFA is reduced and the intake of n-6 and n-3 PUFAs 
and polyphenols is increased. Thus, genes related to immune response and inflammation 
represent possible gene targets modulated by a healthy dietary pattern in metabolically active 
tissues. Components of the ND, such as n-3 PUFAs and phytochemicals may decrease the 
expression of inflammation-related genes through attenuation of the NF-B pathway [48, 49]. In 
addition, the fiber intake was higher in the ND compared to the CD group 
[16]
. Dietary fibers 
may be fermented to short-chain fatty acids (SCFAs) by the gut microbiota. Recent studies 
suggest that SCFAs exert multiple beneficial effects on mammalian energy metabolism and 
may beneficial influence inflammation status in the circulation 
[50]
. 
 Gene transcripts related cellular processes such as cell division, -proliferation and –
growth and apoptosis were down-regulated by ND compared to CD (Table 4, 6), indicating 
that intake of ND has an impact on basic cellular processes.. Interestingly, intake of fish oil 
has previously been shown to modulate expression of genes related cell cycle and apoptosis 
[51]
. Whether the effects reported in the current study are specific to n-3 fatty acids remains to 
be elucidated. It is also tempting to speculate whether changes in these basic cellular 
processes by ND are linked to altered mitochondrial function and thereby ROS production. 
Intracellular ROS are known to act as signaling molecules and are essential for regulation of 
physiological functions such as cell cycle progression and proliferation, differentiation and 
apoptosis 
[52, 53]
. 
The two groups differed in the consumption of fiber, fatty acids and a large number of 
micronutrients and non-nutritive phytochemicals and the limitation of the study is that it is 
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not possible to determine which dietary component specifically explains the effect on the 
transcriptome. The observed changes in the transcriptome profile may actually not be linked 
to a direct effect of the dietary components on PBMCs, but rather reflect metabolic changes 
due to long-term nutritional adaptation in the whole body. Long-term metabolic adaptations 
have been linked to a favorable change in the transcriptome profile of PBMCs after the intake 
of fish oil (1.8 g EPA + DHA/d) for 26 weeks in elderly subjects 
[54]
.  
The majority of the regulated probe sets were down-regulated in the ND group 
compared to the CD group. This is in line with the transcriptome data obtained from the 
abdominal subcutaneous adipose tissue samples in the same study, where a similar regulation 
pattern was observed 
[18]
. The magnitude of the gene expression changes observed in the ND 
compared to the CD group ranged from +47 % and -28 % (Table S1). The effect size is small, 
but are in line with the findings of other dietary transcriptome studies [19, 51]. It is however, 
recognized that this effect over time will have an impact on the disease development 
[55]
. The 
intervention varied from 18 weeks to 24 weeks and we cannot rule out the possibility that 
differences in duration time may have influenced the results. In order to remove effects that 
correlates to study center (duration time) and get a more precise estimate of the dietary effect, 
we have therefore adjusted the linear regression analyses for study centers as a covariate. In 
the present study, the changes in gene expression in the ND group were compared to the 
changes in a control group. The reported effects are therefore directly linked to the ND and 
changes in gene expression caused by the ritual of the intervention or to daily fluctuations in 
the transcriptome are excluded. Previous dietary intervention studies that examined the 
transcriptome profile have often reported solely within- group changes 
[27, 54]
 or did not have a 
control arm at all
 [56]
.  
The current data must be interpreted in relation to PBMCs and whether the observed 
changes in gene expression do have any impact on whole-body metabolic regulation is not 
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known. There are however, studies indicating that gene expression in PBMCs seem to reflect 
changes occurring in metabolically active organs such as the liver, adipose tissue and skeletal 
muscle 
[20, 57-59]. Furthermore, PBMCs are directly involved in the complex inflammation 
processes that underlie many lifestyle-related diseases. 
In conclusion, we have shown that a healthy Nordic dietary pattern modulates the 
expression of genes involved in mitochondrial function and immune response in PBMCs of 
subjects with the MetS. In particular, we observed a reduced expression of genes related to 
ETC after a prolonged intake of a healthy Nordic diet. Although the impact of reduced 
expression of ETC genes at the cellular level in PBMCs needs to be addressed, the current 
findings may offer new mechanistic insight into the effects of a healthy diet on disease 
prevention.   
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Supporting Information 
Table S1. Changes in gene expression calculated with a linear regression model. 
Table 1. Baseline characteristics of individuals in the ND and CD groups participating in the PBMC 
transcriptomic SYSDIET sub-study. 
 ND (n=40) CD (n=26) 
Sex (female) 29 (73%) 17 (65%) 
Age (years) 54.0 (8.9) 54.9 (7.7) 
BMI (kg/m
2
) 32.0 (3.2) 31.8 (2.7) 
Total cholesterol (mmol/L) 5.54 (1.01) 5.76 (0.74) 
LDL cholesterol (mmol/L) 3.52 (0.86) 3.67 (0.68) 
HDL cholesterol (mmol/L) 1.35 (0.28) 1.39 (0.50) 
Triglycerides (mmol/L) 1.50 (0.73) 1.54 (0.53) 
0 h Glucose (mmol/L) 5.8 (0.7) 5.7 (0.5) 
2 h Glucose (mmol/L) 6.3 (1.3) 6.2 (2.1) 
Systolic BP (mmHg) 127 (14) 133 (16) 
Diastolic BP (mmHg) 83 (11) 85 (11) 
The results are given as mean (SD) values and female as number (%). ND: Healthy Nordic diet, CD: Control 
diet, PBMC: Peripheral blood mononuclear cells, BP: Blood pressure. 
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Table 2. Dietary data at baseline (week 0) and end of the study (week 18/24) in the ND and in CD group, and the differences in dietary variables at the end of the 
study with 95% CI. 
 
ND (n=40) 
Baseline 
 
End 
CD (m=26) 
Baseline 
 
End 
Estimate 
(95% CI) 
P-value
a
 
Energy (kJ) 8127 (1779) 8346 (1743) 7914 (2152) 8133 (1816) -8 (-617 to 601) 0.98 
Carbohydrate (E%) 45.3 (6.0) 46.2 (5.9) 45.5 (7.5) 43.2 (6.5) 3.20 (0.64 to 5.75) 0.014 
Sucrose (g) 42.0 (15.5) 38.2 (15.8) 38.8 (18.1) 35.6 (16.6) -0.54 (-6.97 to 5.89) 0.87 
Protein (E%) 17.0 (2.8) 17.0 (2.3) 17.3 (2.8) 16.4 (2.2) 0.88 (-0.26 to 2.01) 0.13 
Fat (E%) 33.0 (6.6) 32.2 (5.0) 32.8 (6.7) 36.0 (5.6) -3.88 (-6.47 to -1.30) 0.0034 
SFA (E%) 13.1 (3.0) 10.4 (2.2) 13.2 (3.8) 15.3 (3.1) -4.84 (-6.18 to -3.50) 2.1e-11 
MUFA (E%) 11.6 (2.7) 12.2 (2.3) 11.7 (2.3) 12.8 (2.1) -0.49 (-1.56 to 0.58) 0.37 
PUFA (E%) 5.1 (1.3) 6.7 (1.8) 4.6 (1.7) 4.6 (1.1) 1.70 (0.95 to 2.44) 1.2e-05 
Fiber (g) 22.4 (7.8) 35.7 (11.2) 21.0 (5.5) 15.7 (3.8) 18 (15 to 22) 2.1e-20 
Beta-carotene (µg) 2502 (1938) 3423 (2521) 2328 (1671) 1744 (1029) 1498 (507 to 2488) 0.0032 
Folate (µg) 279 (96) 323 (132) 245 (64) 225 (76) 63.6 (11.2 to 116.0) 0.018 
Alcohol (E%) 2.6 (3.9) 2.3 (3.9) 2.7 (3.2) 3.5 (4.1) -1.22 (-2.65 to 0.22) 0.096 
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Data are given as mean (SD) and the differences in variables (Estimate) at the end of the study with 95% CI. 
a 
Linear mixed-effects models as previously described [16]. 
Estimate: the difference between the changes in the ND compare to the CD group when adjusted for covariates. ND: Healthy Nordic diet, CD: Control diet, SFA: 
Saturated fatty acids, MUFA: Monounsaturated fatty acids, PUFA: Polyunsaturated fatty acids 
 
www.mnf-journal.com Page 32 Molecular Nutrition & Food Research 
32 
This article is protected by copyright. All rights reserved. 
Table 3. Main clinical and biochemical characteristics at baseline (week 0) and at the end of the study (18/24 week). 
Data 
are 
give
n as 
mean 
(SD) 
and 
the 
diffe
rence
s in 
varia
bles 
at the 
end 
of 
the 
study 
with 
95% CI. 
#
 Linear mixed-effects models adjusted as previously described [16]. Estimate: the difference between the changes in the ND compare to change in the CD group 
when adjusted for covariates. ND: Healthy Nordic diet, CD: Control diet 
 
 ND (n=40) CD (n=26)   
 Baseline  End  Baseline  End  Estimate (95% CI) p-value
#
 
Body weight (kg) 88.2 (13.4) 88.8 (14.1) 90.6 (14.9) 91.60 (14.8) -0.52 (-1.45 to 0.41) 0.27 
Total cholesterol (mmol/l) 5.54 (1.01) 5.34 (0.95) 5.76 (0.74) 5.76 (0.68) -0.21 (-0.47 to 0.05) 0.12 
LDL cholesterol (mmol/l) 3.52 (0.86) 3.28 (0.79) 3.67 (0.68) 3.71 (0.66) -0.28 (-0.50 to -0.05) 0.018 
HDL cholesterol (mmol/l) 1.35 (0.28) 1.43 (0.35) 1.39 (0.50) 1.40 (0.41) 0.06 (-0.03 to 0.15) 0.19 
Triglyceride (mmol/l) 1.50 (0.73) 1.41 (0.78) 1.54 (0.53) 1.44 (0.48) 0.02 (-0.20 to 0.23) 0.88 
IL-1Ra (ng/l) 376 (219) 381 (228) 340 (157) 430 (270) -82 (-162 to -1) 0.047 
hsCRP (mg/l) 2.5 (2.1) 2.7 (2.0) 2.3 (2.0) 2.2 (1.7) 0.30 (-0.53 to 1.13) 0.48 
0h Glucose (mmol/l) 5.83 (0.65) 5.79 (0.64) 5.66 (0.47) 5.59 (0.63) 0.04 (-0.16 to 0.23) 0.72 
2h Glucose (mmol/l) 6.25 (1.34) 6.78 (1.74) 6.22 (2.06) 6.23 (1.98) 0.51 (-0.14 to 1.16) 0.12 
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ID Gene Symbol CD  
(change) 
ND 
Change) 
ND vs CD (estimate)  95% CI FDR BP or protein function 
8043036 DHFR 0.38 -0.09 -0.46 (-0.66, -0.26) 0.19 Dihydrofolat reductase 
metabolism, cell cycle 
7982712 KNSTRN 0.21 -0.07 -0.28 (-0.42, -0.14) 0.20 Cell division, kinetochore 
8022106 LINC00526 0.13 -0.13 -0.26 (-0.39, -0.13) 0.21 Non-coding RNA 
7957530 LOC400590 0.21 -0.02 -0.23 (-0.34, -0.11) 0.24 Unkown 
7940669 UQCC3 0.12 -0.10 -0.22 (-0.32, -0.12) 0.19 Mitochondrial electron transport, 
ATP biosyntetic process 
8054297 CHST10 0.16 -0.06 -0.21 (-0.32, -0.11) 0.21 Cell adhesion, T- cell adhesion, 
sulfo-transferase activity  
7978114 EMC9 0.10 -0.10 -0.21 (-0.30, -0.12) 0.19 ER membrane, unknown function  
8018352 SLC25A19 0.14 -0.07 -0.20 (-0.30, -0.09) 0.23 Mitochondrial transport, transports 
thiamine pyrophosphates into 
mitochondria 
8155327 ALDH1B1 0.14 -0.06 -0.19 (-0.28, -0.1) 0.20 Aldehyd dehydrogenase (NAD) 
activity, mitochondrial matrix 
8063955 OGFR 0.10 -0.08 -0.18 (-0.27, -0.09) 0.20 Regulation of cell growth, opioid 
receptor-signalling 
7917896 ALG14 0.17 -0.02 -0.18 (-0.27, -0.09) 0.23 Protein modification, N-linked 
glycosylation 
8086462 POMGNT2 0.10 -0.08 -0.18 (-0.27, -0.09) 0.23 Protein modification, protein O-
linked glycosylation 
8044491 CHCHD5 0.11 -0.06 -0.17 (-0.26, -0.08) 0.24 Mitochondrial respiratory chain, 
mitochondrial import 
8169645 UBE2A 0.14 -0.02 -0.17 (-0.25, -0.08) 0.23 DNA repair, histone ubiquitination 
8063949 MRGBP 0.11 -0.06 -0.17 (-0.24, -0.09) 0.19 Histone acetylation, regulation of 
cell growth 
8040831 ATRAID 0.08 -0.07 -0.16 (-0.23, -0.09) 0.19 Cell differentiation, apoptosis, 
regulation of gene expression 
7934133 PPA1 0.10 -0.05 -0.15 (-0.23, -0.07) 0.23 Diphosphate metabolic process, 
cell division 
8078984 RPL14 0.07 -0.08 -0.15 (-0.22, -0.07) 0.23 Ribosomal biogenesis 
8164428 TRUB2 0.05 -0.10 -0.14 (-0.21, -0.07) 0.23 Pseudouridine synthesis in 
mitochondria 
8141708 CLDN15 0.09 -0.05 -0.14 (-0.21, -0.07) 0.23 Cell-cell adhesion, tight junction 
8169683 ZBTB33 0.14 0.00 -0.14 (-0.20, -0.07) 0.21 Wnt-signaling pathway, apoptosis, 
transcription factor activity 
7940051 ZDHHC5 0.07 -0.03 -0.10 (-0.15, -0.06) 0.19 Protein modification, protein 
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Table 4. Gene transcripts differently expressed in the ND group compared to the CD group (FDR q-value < 
0.25). 
Differential expressed gene transcripts were calculated with a linear regression model adjusted for age, gender 
and study center and with log2 ratio as the dependent variable.  Change in ND or CD is given as log2 ratio from 
baseline (log2(18/24 weeks) – log2(baseline)). Change in ND vs CD is given as adjusted log2 ratio (log2 ratio 
ND-log2 ratio CD). FDR with q-value < 0.25 was considered significant. ND: healthy Nordic diet, CD: control 
diet, FDR: False discovery rate, BP: Biological Process. 
palmitoylation 
7911683 FAAP20 -0.16 0.02 0.17 (0.08, 0.25) 0.21 Cellular response to DNA damage 
stimulus 
7898585 NBL1 -0.21 0.11 0.31 (0.16, 0.47) 0.20 Regulation of monocyte 
chemotaxis 
8108470  -0.21 0.12 0.33 (0.16, 0.5) 0.23 unknown 
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Table 5. The probe sets significantly down-regulated in the ND vs CD group (p-value 0.05, Table S1) are 
visualized using Metacore Pathway Maps. Significant Pathway Maps (FDR q-value <0.05).  
 
 
PATHWAY MAPS RATIO FDR 
IMMUNE RESPONSE_ANTIGEN PRESENTATION BY 
MHC CLASS I, CLASSICAL PATHWAY 
11/54 0.00 
UBIQUINONE METABOLISM 11/74 0.00 
NEUROPHYSIOLOGICAL PROCESS_DYNEIN-
DYNACTIN MOTOR COMPLEX IN AXONAL TRANSPORT 
IN NEURONS 
9/54 0.00 
REGULATION OF DEGRADATION OF DELTAF508-
CFTR IN CF 
7/39 0.01 
CYTOSKELETON REMODELING_NEUROFILAMENTS 5/25 0.04 
Ratio indicates the number of genes among down-regulated/number of genes represented in the pathway maps. 
ND: healthy Nordic diet, CD: control diet, FDR: False discovery rate. 
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Table 6: Enriched biological processes in the ND group compared to the CD group among the 927 down-regulated probe sets (p-value < 0.05 
 
BIOLOGICAL PROCESS GENE SYMBOLS FOLD 
ENRICHMENT 
FDR (%) 
GO:0006364~RRNA PROCESSING RPL17, NAF1, RPL14, RPL15, UTP15, RPLP2, WBP11, PIN4, RPP14, EXOSC10, EBNA1BP2, RPS26, 
RPS28, RPL8, RPL10, MTERF4, CCDC86, RPP21, RRP36, PNO1, RPL26, ISG20L2, FBL, PWP2, SENP3, 
RCL1, NOLC1, RPL13A, RPS14, YBEY 
3.22 0.00 
GO:0032981~MITOCHONDRIAL 
RESPIRATORY CHAIN COMPLEX I 
ASSEMBLY 
ND1, NDUFAF5, NDUFB11, NDUFA2, ND5, NDUFB8, NDUFA6, ND2, ND3, NDUFS5, NDUFS4, 
FOXRED1, NDUFS3, ND6 
5.10 0.00 
GO:0006120~MITOCHONDRIAL ELECTRON 
TRANSPORT, NADH TO UBIQUINONE 
ND1, NDUFB11, NDUFA2, NDUFS5, NDUFS4, NDUFB8, ND5, NDUFA6, ND2, ND3, NDUFS3, ND6 5.63 0.01 
GO:0006412~TRANSLATION MRPS36, RPL17, RPL14, RPL15, RPLP2, IGHMBP2, RPS26, RPS28, MRPL14, MRPL17, SLC25A22, RPL8, 
MRPL19, RPL10, SLC25A43, RPL26, GTF2H3, MRPS21, MRPS7, SLC25A12, RSL1D1, MRPS18A, 
SLC25A33, RPL13A, RPS14, SLC25A19, PELO, DHPS 
2.54 0.03 
GO:0008033~TRNA PROCESSING ADAT1, PUS3, ELAC2, RPP21, TRMT2B, TRMT10C, FDXACB1, TRUB2, POP7, FBL 6.21 0.04 
GO:0007049~CELL CYCLE ARL2, ERH, LIN52, STK10, LIN9, CINP, THAP5, TP53, HCFC1, ARF6, SENP5, GAK, MAPK6, NOLC1, 
CCDC124, MAP3K8, PELO, THAP1, SUPT5H, CDK20, CHAF1B, RAD17, CCAR2 
2.43 0.35 
GO:0006368~TRANSCRIPTION ELONGATION 
FROM RNA POLYMERASE II PROMOTER 
TAF2, ENY2, CCNK, POLR2J, CDK9, GTF2H3, CDK7, ADRM1, GTF2F1, SUPT4H1, TCEB1, NELFE, 
SUPT5H 
3.47 0.58 
GO:0007005~MITOCHONDRION 
ORGANIZATION 
TFAM, ALAS1, ESRRA, NRF1, FXN, SLC25A33, RAB29, HCFC1, STOML2, FANCG, DNAJA3 3.28 3.08 
GO:0001522~PSEUDOURIDINE SYNTHESIS NAF1, PUS3, RPUSD3, RPUSD1, TRUB2 8.84 3.18 
GO:0006614~SRP-DEPENDENT 
COTRANSLATIONAL PROTEIN TARGETING 
TO MEMBRANE 
RPL17, RPS26, SRP54, RPS28, RPL14, RPL13A, RPS14, RPL15, RPL8, RPL26, RPL10, RPLP2 2.93 4.31 
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Enriched biological processes were identified using DAVID (FDR q-value < 0.05). ND: healthy Nordic diet, CD: control diet, GO, Gene ontology term; FDR, false discovery 
rate. 
www.mnf-journal.com Page 38 Molecular Nutrition & Food Research 
Received: 12 21, 2018; Revised: 03 20, 2019; Accepted: 03 28, 2019  
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process, which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/mnfr.201801405. 
This article is protected by copyright. All rights reserved. 
Table 7. Overrepresentation of regulatory motives for transcription factors among the gene transcripts 
significantly down-regulated (p-value < 0.05) in the ND group compared to the CD group. 
Transcription Factor Actual n R N Expected Ratio z-score 
ATF-6 alpha (90kDa)  5 908 24 38951 0.56 8.94 6.01 
THAP11 7 908 41 38951 0.96 7.32 6.26 
STAT4 8 908 64 38951 1.49 5.36 5.40 
LXR-beta  5 908 41 38951 0.96 5.23 4.19 
PXR 5 908 41 38951 0.96 5.23 4.19 
SREBP1 precursor 7 908 61 38951 1.42 4.92 4.74 
SREBP2 (nuclear)  8 908 71 38951 1.66 4.83 5.00 
MEIS1  10 908 92 38951 2.15 4.66 5.43 
BLIMP1 (PRDI-BF1)  10 908 95 38951 2.22 4.52 5.30 
SREBP1 (nuclear)  14 908 144 38951 3.36 4.17 5.89 
LXR-alpha  10 908 104 38951 2.42 4.13 4.93 
Miz-1  11 908 116 38951 2.70 4.07 5.11 
FOXK1  7 908 75 38951 1.75 4.00 4.02 
IRF2  7 908 76 38951 1.77 3.95 3.98 
ZNF143  89 908 984 38951 22.94 3.88 14.14 
ZNF217  9 908 101 38951 2.35 3.82 4.39 
YY1  89 908 1157 38951 26.97 3.30 12.27 
c-Myc  185 908 2544 38951 59.30 3.12 17.08 
NRF2  16 908 227 38951 5.29 3.02 4.72 
NF-kB1 (p50) 32 908 476 38951 11.10 2.88 6.39 
NRF1  12 908 181 38951 4.22 2.84 3.84 
STAT6 26 908 398 38951 9.28 2.80 5.58 
RelB  13 908 208 38951 4.85 2.68 3.76 
XBP1 10 908 160 38951 3.73 2.68 3.29 
CTCF 11 908 184 38951 4.29 2.57 3.29 
IRF4  26 908 440 38951 10.26 2.54 5.00 
CREB1  289 908 5124 38951 119.40 2.42 16.84 
GATA-3  37 908 657 38951 15.32 2.42 5.65 
DBP 21 908 388 38951 9.05 2.32 4.04 
MYOG  16 908 301 38951 7.02 2.28 3.45 
CUX1 (p110) 72 908 1387 38951 32.33 2.23 7.19 
HSF1  15 908 298 38951 6.95 2.16 3.10 
PU.1 20 908 406 38951 9.46 2.11 3.48 
E2F1  42 908 863 38951 20.12 2.09 4.99 
SRF  20 908 414 38951 9.65 2.07 3.39 
EGR1  22 908 470 38951 10.96 2.01 3.40 
NANOG  33 908 730 38951 17.02 1.94 3.96 
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p53 56 908 1318 38951 30.72 1.82 4.69 
Oct-3/4  52 908 1245 38951 29.02 1.79 4.39 
SP1 70 908 1684 38951 39.26 1.78 5.08 
ESR1 (nuclear)  54 908 1321 38951 30.79 1.75 4.31 
RelA 59 908 1541 38951 35.92 1.64 3.98 
 
The analyses was performed in Metacore. Transcription factor in italics are presented in the list of down-
regulated probe sets. ND: healthy Nordic diet, CD: control diet. 
Actual; number of network objects in the dataset, which interact with the chosen object 
n; number of network objects in the dataset.  
R; number of network objects in the background list, which interact with the chosen object  
N; total number of gene-based objects in the background list 
Expected; mean value for hypergeometric distribution (n*R/N) 
Ratio; connectivity ratio (Actual/Expected) 
z-score;  Actual/Expected/sqrt(variance) 
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Table 8. The gene transcripts significantly up-regulated in the ND vs CD group (p-value < 0.05, Table S1) are 
visualized using Metacore Pathway Maps. Significant Pathway Maps (FDR q-value < 0.05).  
PATHWAY MAPS RATIO FDR 
CYTOSKELETON REMODELING_KERATIN FILAMENTS 4/36 0.023 
Ratio indicates the number of genes represented in the pathway maps/number of genes among up-regulated. 
ND: healthy Nordic diet, CD: control diet, FDR: False discovery rate. 
 
 
Table 9. Overrepresentation of regulatory motives for transcription factors among the gene transcripts 
significantly up-regulated (p-value < 0.05) in the ND group compared to the CD group. 
Transcription factor Actual n R N Expected Ratio z-score 
MTG16 (CBFA2T3) 3 273 17 38951 0.12 25.18 8.38 
CREB1 66 273 5124 38951 35.91 1.84 5.41 
The analyses was performed in Metacore. ND: healthy Nordic diet, CD: control diet. 
Actual; number of network objects in the dataset, which interact with the chosen object 
n; number of network objects in the dataset. 
R; number of network objects in the background list, which interact with the chosen object  
N; total number of gene-based objects in the background list 
Expected; mean value for hypergeometric distribution (n*R/N) 
Ratio; connectivity ratio (Actual/Expected) 
z-score;  Actual/Expected/sqrt(variance)  
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Figure legends 
 
Figure 1. Flow chart showing the number of subjects included in the microarray 
analyses. The inclusion of study participants from the three study centers Kuopio, Oulu and 
Lund was based on the following criteria: weight change during the study < 4 kg, no use of 
statins, high-sensitivity (hs) CRP < 10 mg/L at baseline and at the end of the intervention, 
and BMI < 39 kg/m
2
. ND: healthy Nordic diet, CD: control diet 
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Figure 2. RT-qPCR validation of microarray findings.  The changes in mRNA expression 
in the ND group compared to the CD group, adjusted for age, gender and study center, were 
analyzed with microarray (pink) and qPCR (green). Dots represent the log ratio (β-
coefficient) and the lines represent the 95 % CI. Solid dots represent a significant change (p-
value < 0.05), while empty dots represent a non-significant change (p-value  ≥ 0.05).  
 
 
 
